These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 18506103)
21. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Ballestar E; Yusufzai TM; Wolffe AP Biochemistry; 2000 Jun; 39(24):7100-6. PubMed ID: 10852707 [TBL] [Abstract][Full Text] [Related]
22. The Ski protein family is required for MeCP2-mediated transcriptional repression. Kokura K; Kaul SC; Wadhwa R; Nomura T; Khan MM; Shinagawa T; Yasukawa T; Colmenares C; Ishii S J Biol Chem; 2001 Sep; 276(36):34115-21. PubMed ID: 11441023 [TBL] [Abstract][Full Text] [Related]
23. Structure-specific binding of MeCP2 to four-way junction DNA through its methyl CpG-binding domain. Galvão TC; Thomas JO Nucleic Acids Res; 2005; 33(20):6603-9. PubMed ID: 16314321 [TBL] [Abstract][Full Text] [Related]
24. MeCP2 binding to DNA depends upon hydration at methyl-CpG. Ho KL; McNae IW; Schmiedeberg L; Klose RJ; Bird AP; Walkinshaw MD Mol Cell; 2008 Feb; 29(4):525-31. PubMed ID: 18313390 [TBL] [Abstract][Full Text] [Related]
25. The role of MeCP2 in the brain. Guy J; Cheval H; Selfridge J; Bird A Annu Rev Cell Dev Biol; 2011; 27():631-52. PubMed ID: 21721946 [TBL] [Abstract][Full Text] [Related]
26. Differential methylation of the micro-RNA 7b gene targets postnatal maturation of murine neuronal Mecp2 gene expression. Chen Y; Shin BC; Thamotharan S; Devaskar SU Dev Neurobiol; 2014 Apr; 74(4):407-425. PubMed ID: 24039126 [TBL] [Abstract][Full Text] [Related]
27. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136 [TBL] [Abstract][Full Text] [Related]
28. Regulation of transcription and chromatin by methyl-CpG binding protein MBD1. Nakao M; Matsui S; Yamamoto S; Okumura K; Shirakawa M; Fujita N Brain Dev; 2001 Dec; 23 Suppl 1():S174-6. PubMed ID: 11738867 [TBL] [Abstract][Full Text] [Related]
29. Methyl CpG-binding proteins and transcriptional repression. Wade PA Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232 [TBL] [Abstract][Full Text] [Related]
30. CpG methylation and the methyl CpG binding protein 2 (MeCP2) are required for restraining corticotropin releasing hormone (CRH) gene expression. Bhave SA; Uht RM Mol Cell Endocrinol; 2017 Oct; 454():158-164. PubMed ID: 28655627 [TBL] [Abstract][Full Text] [Related]
31. Investigation of the interaction between MeCP2 methyl-CpG binding domain and methylated DNA by single molecule force spectroscopy. Qin J; Zhang M; Guan Y; Li C; Ma X; Rankl C; Tang J Anal Chim Acta; 2020 Aug; 1124():52-59. PubMed ID: 32534675 [TBL] [Abstract][Full Text] [Related]
32. Functional conservation of MBD proteins: MeCP2 and Drosophila MBD proteins alter sleep. Gupta T; Morgan HR; Bailey JA; Certel SJ Genes Brain Behav; 2016 Nov; 15(8):757-774. PubMed ID: 27489246 [TBL] [Abstract][Full Text] [Related]
33. Multiple binding of methyl-CpG and polycomb proteins in long-term gene silencing events. Matarazzo MR; De Bonis ML; Strazzullo M; Cerase A; Ferraro M; Vastarelli P; Ballestar E; Esteller M; Kudo S; D'Esposito M J Cell Physiol; 2007 Mar; 210(3):711-9. PubMed ID: 17133344 [TBL] [Abstract][Full Text] [Related]
34. Gene silencing by methyl-CpG-binding proteins. Nan X; Cross S; Bird A Novartis Found Symp; 1998; 214():6-16; discussion 16-21, 46-50. PubMed ID: 9601009 [TBL] [Abstract][Full Text] [Related]
37. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Schanen C; Tamura M J Med Genet; 2003 Jul; 40(7):487-93. PubMed ID: 12843318 [TBL] [Abstract][Full Text] [Related]
38. Cocaine represses protein phosphatase-1Cβ through DNA methylation and Methyl-CpG Binding Protein-2 recruitment in adult rat brain. Pol Bodetto S; Carouge D; Fonteneau M; Dietrich JB; Zwiller J; Anglard P Neuropharmacology; 2013 Oct; 73():31-40. PubMed ID: 23688924 [TBL] [Abstract][Full Text] [Related]
39. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347 [TBL] [Abstract][Full Text] [Related]
40. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Nan X; Campoy FJ; Bird A Cell; 1997 Feb; 88(4):471-81. PubMed ID: 9038338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]